< Back to situations

[ORGANIZATION]

Andos

Featured in 3 tracked stories · first seen

Situations

[QUIET] [HEALTH] [CN] [IT]

Osimertinib efficacy and evolving NSCLC treatment trends

4 clusters · 18 sources · last updated

Latest: Italy advances cancer prevention and oncology treatments

Updated data from the Phase III ADAURA study, presented at the World Conference on Lung Cancer in Seoul, indicates that osimertinib provides sustained and clinically significant overall survival benefits for patients wit

Also covered in